Becker's Clinical Quality & Infection Control

November/December 2020 IC_CQ

Issue link: https://beckershealthcare.uberflip.com/i/1311160

Contents of this Issue

Navigation

Page 46 of 47

#1 Brand in Daily Nasal Decolonization 1. Arden S. Does Universal Nasal Decolonization with an Alcohol-Based Nasal Antiseptic Reduce Infection Risk and Cost? Open Forum Infect Dis 2019 Oct; 6(Suppl 2): S26. 2. References list: https://www.nozin.com/clinical-outcomes. Outcomes reported by actual users. Your results may vary. Nozin® Nasal Sanitizer® antiseptic is for nasal decolonization. ©2020 Global Life Technologies Corp. All rights reserved. Made in USA. Nozin®, Nasal Sanitizer®, Popswab®, NOVA SM and Nozaseptin® are trademarks of Global Life Technologies Corp. Nozin® Nasal Sanitizer® antiseptic is an OTC topical drug. No claim is made that it has an effect on any specific disease. Patent nos.: nozin.com/patents. Welcome to NOVA SM by Nozin. NOVA SM programs are a proprietary suite of analytical tools and services, guided by experienced consultants and proven to reduce infection risks while improving patient care. WE CAN HELP GET YOU THERE. NOVA SM is powered by Call: 877-669-4648 Email: NOVA@nozin.com Proven MRSA / MSSA colonization risk mitigation programs. Speak to a NOVA SM professional. REDUCING MRSA INFECTION RATES BY 96% 1 IS NOT EASY. NOVA SM programs are working nationwide. The NOVA SM approach is clinically proven to help reduce MRSA infection risks up to 100%, decrease contact precautions 42%, increase patient as well as staff satisfaction and save up to $1.4 million in a year. 2

Articles in this issue

Links on this page

view archives of Becker's Clinical Quality & Infection Control - November/December 2020 IC_CQ